RECURRENT NON-CUTANEOUS MELANOMA

Clinical trials for RECURRENT NON-CUTANEOUS MELANOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT NON-CUTANEOUS MELANOMA trials appear

Sign up with your email to follow new studies for RECURRENT NON-CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major cancer trial tests new drug to stop deadly Melanoma's return

Disease control Ongoing

This large, late-stage trial is testing if a drug called pembrolizumab works better than current standard treatments to prevent melanoma skin cancer from coming back or spreading after surgery. It enrolled over 1,300 patients with high-risk stage III or IV melanoma whose tumors w…

Matched conditions: RECURRENT NON-CUTANEOUS MELANOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

RECURRENT NON-CUTANEOUS MELANOMA

Get alerted when new RECURRENT NON-CUTANEOUS MELANOMA trials appear

Major cancer trial tests new drug to stop deadly Melanoma's return